Instrument Inactif

Autres langues BioTelemetry, Inc.

Actions

BEAT

US0906721065

Autres langues

Débloquez toutes les actualités : Soyez le premier informé et réagissez avant les marchés !

Ayala Pharmaceuticals, Inc. announced that it has received $2 million in funding from Israel Biotech Fund, Arkin Bio Venture Partners Ltd., BioTelemetry, Inc.	01/03
Ayala Pharmaceuticals, Inc. announced that it has received $4 million in funding from Israel Biotech Fund, Arkin Bio Venture Partners Ltd., BioTelemetry, Inc.	17/11
Ayala Pharmaceuticals, Inc. entered into a definitive merger agreement to acquire BioSight Ltd from Israel Biotech Fund, BioTelemetry, Inc., Arkin Bio Venture Partners Ltd., Primera Capital, SBI JI Innovation Advisory Ltd., Migdal Insurance Company Ltd., The Phoenix Insurance Company Ltd. and others.	27/07/23
Koninklijke Philips N : Philips completes the acquisition of BioTelemetry, Inc	10/02/21
Koninklijke Philips N : Philips completes the acquisition of BioTelemetr Inc	10/02/21
Koninklijke Philips N : Philips successfully completes tender offer for BioTelemetry Inc	10/02/21
BioTelemetry, Inc.(NasdaqGS:BEAT) dropped from S&P Health Care Services Select Industry Index	10/02/21
BioTelemetry, Inc.(NasdaqGS:BEAT) dropped from S&P 600	10/02/21
BioTelemetry, Inc.(NasdaqGS:BEAT) dropped from S&P Composite 1500	10/02/21
BioTelemetry, Inc.(NasdaqGS:BEAT) dropped from S&P 600 Health Care Services (Sub Ind)	10/02/21
BioTelemetry, Inc.(NasdaqGS:BEAT) dropped from S&P 1000	10/02/21
BioTelemetry, Inc.(NasdaqGS:BEAT) dropped from S&P TMI Index	10/02/21
BioTelemetry, Inc.(NasdaqGS:BEAT) dropped from S&P Global BMI Index	10/02/21
BioTelemetry, Inc.(NasdaqGS:BEAT) dropped from S&P 600 Health Care	10/02/21
BIOTELEMETRY, INC. : Termination of a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control or Registrant, Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)	09/02/21
BioTelemetry, Inc. Announces Board Changes	09/02/21
BioTelemetry, Inc. Terminates Amended and Restated Credit Agreement	09/02/21
Koninklijke Philips N : Royal Philips Completes Tender Offer to Acquire BioTelemetry at $72 per Share	09/02/21
Philips rondt bod op BioTelemetry af	09/02/21
BioTelemetry, Inc.(NasdaqGS:BEAT) dropped from NASDAQ Composite Index	09/02/21

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues BioTelemetry, Inc.

Actions

BEAT

US0906721065

Autres langues

Filtres